These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 16837130

  • 1. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
    Liu Y, Poon RT, Shao W, Sun X, Chen H, Kok TW, Fan ST.
    Cancer Lett; 2007 Apr 08; 248(1):32-40. PubMed ID: 16837130
    [Abstract] [Full Text] [Related]

  • 2. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
    Huang WC, Hsu RM, Chi LM, Leu YL, Chang YS, Yu JS.
    Cancer Lett; 2007 Apr 08; 248(1):137-46. PubMed ID: 16919867
    [Abstract] [Full Text] [Related]

  • 3. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG.
    Cancer Res; 2006 Jan 01; 66(1):404-11. PubMed ID: 16397255
    [Abstract] [Full Text] [Related]

  • 4. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 01; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 5. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B, Chang CM, Yuan M, McKenna WG, Shu HK.
    Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544
    [Abstract] [Full Text] [Related]

  • 6. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 01; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 7. Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.
    Höpfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, Scherübl H.
    J Hepatol; 2004 Dec 01; 41(6):1008-16. PubMed ID: 15582135
    [Abstract] [Full Text] [Related]

  • 8. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Dec 01; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

  • 9. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase.
    Moyer JD, Barbacci EG, Iwata KK, Arnold L, Boman B, Cunningham A, DiOrio C, Doty J, Morin MJ, Moyer MP, Neveu M, Pollack VA, Pustilnik LR, Reynolds MM, Sloan D, Theleman A, Miller P.
    Cancer Res; 1997 Nov 01; 57(21):4838-48. PubMed ID: 9354447
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW, Palmer BD, Bridges AJ, Showalter HD, Sun L, Nelson J, McMichael A, Kraker AJ, Fry DW, Denny WA.
    J Med Chem; 1996 Feb 16; 39(4):918-28. PubMed ID: 8632415
    [Abstract] [Full Text] [Related]

  • 11. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
    Ahmad N, Gali H, Javed S, Agarwal R.
    Biochem Biophys Res Commun; 1998 Jun 18; 247(2):294-301. PubMed ID: 9642119
    [Abstract] [Full Text] [Related]

  • 12. Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.
    Harper ME, Goddard L, Glynne-Jones E, Assender J, Dutkowski CM, Barrow D, Dewhurst OL, Wakeling AE, Nicholson RI.
    Prostate; 2002 Jun 01; 52(1):59-68. PubMed ID: 11992620
    [Abstract] [Full Text] [Related]

  • 13. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR.
    Cancer Res; 2006 Jun 15; 66(12):6296-303. PubMed ID: 16778206
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR, Bradley SV, Fuchshuber S, Conover CA.
    Gynecol Oncol; 2004 Sep 15; 94(3):705-12. PubMed ID: 15350362
    [Abstract] [Full Text] [Related]

  • 15. Differential responses of EGFR-/AGT-expressing cells to the "combi-triazene" SMA41.
    Matheson SL, McNamee JP, Jean-Claude BJ.
    Cancer Chemother Pharmacol; 2003 Jan 15; 51(1):11-20. PubMed ID: 12497201
    [Abstract] [Full Text] [Related]

  • 16. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY, Yoon SJ, Freire-de-Lima L, Kim JH, Hakomori SI.
    Carbohydr Res; 2009 Aug 17; 344(12):1479-86. PubMed ID: 19559406
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of normal, paramalignant, and malignant human urothelial cells to inhibitors of the epidermal growth factor receptor signaling pathway.
    MacLaine NJ, Wood MD, Holder JC, Rees RW, Southgate J.
    Mol Cancer Res; 2008 Jan 17; 6(1):53-63. PubMed ID: 18234962
    [Abstract] [Full Text] [Related]

  • 18. Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4.
    Kaufmann R, Rahn S, Pollrich K, Hertel J, Dittmar Y, Hommann M, Henklein P, Biskup C, Westermann M, Hollenberg MD, Settmacher U.
    J Cell Physiol; 2007 Jun 17; 211(3):699-707. PubMed ID: 17323377
    [Abstract] [Full Text] [Related]

  • 19. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG, Du Q, Fang WG, Jin ML, Tian XX.
    Int J Oncol; 2008 Sep 17; 33(3):595-602. PubMed ID: 18695891
    [Abstract] [Full Text] [Related]

  • 20. Dual epidermal growth factor receptor and vascular endothelial growth factor receptor inhibition with NVP-AEE788 for the treatment of aggressive follicular thyroid cancer.
    Younes MN, Yazici YD, Kim S, Jasser SA, El-Naggar AK, Myers JN.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3425-34. PubMed ID: 16740767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.